How many acquisitions has Astellas Pharma made so far?

Astellas Pharma has completed 15 acquisitions so far, with an average acquisition amount of $769M.

Which countries does Astellas Pharma usually acquire in?

Astellas Pharma has made acquisitions in 4 countries with the most activity in United States and United Kingdom.

Which is Astellas Pharma's latest acquisition?

Astellas Pharma's most recent acquisition is Propella Therapeutics, a Developer of therapeutics for cancer and arthritis, acquired in December 2023.

Which sectors does Astellas Pharma target for acquisitions?

Most of Astellas Pharma's acquisitions are in Oncology (6) and Genomics (3).

In which year did Astellas Pharma make the most acquisitions?

Astellas Pharma was most active in 2018, with 3 acquisitions completed in that year.

List of 15 Acquisitions by Astellas Pharma (Nov 2026)

Astellas Pharma has made a total of 15 acquisitions. Peak activity occurred in 2018 with 3 acquisitions, while 2020 and 2023 each saw 2 acquisitions. Operations span 13 sectors, including Oncology, Genomics, and Ophthalmology, across 4 countries, including United States, United Kingdom, and Germany. Between 2020 and 2025, the company recorded an average of 0.4 acquisitions per year, with 0 acquisitions completed this year. In December 2023, the firm acquired Propella Therapeutics, a Pittsboro-based developer of cancer and arthritis therapeutics founded in 2020.

Here's the year on year acquisition history of Astellas Pharma:

Number of Total Acquisitions

Year	# Acquisitions
2023	2
2020	2
2019	2
2018	3
2017	1
2016	1
2015	2
2010	1
2007	1

View all Acquisitions by Astellas Pharma

Recent acquisitions by Astellas Pharma

Astellas Pharma's most recent acquisition - Propella Therapeutics is a Developer of therapeutics for cancer and arthritis, founded in 2020 and located in Pittsboro. Astellas Pharma acquired a 100% stake in it in December 2023 for a price of $*****.

Here is the list of all acquisitions by Astellas Pharma sorted by the latest acquisition date:

Acquired on	Acquired Company	Acquisition Price	Facilitators	Stake Acquired	Acquisition Multiple
Dec 22, 2023	Propella Therapeutics	fxmv	bhui	74	205
Apr 29, 2023	IVERIC bio	qpos	runa	61	704
Oct 14, 2020	iota Biosciences	lvjw	wwpn	79	677
Apr 22, 2020	Nanna Therapeutics	cvbw	cenl	98	337
Dec 26, 2019	Xyphos	afwh	nukq	68	520